Stocks and Investing Stocks and Investing
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023

Ed Arce Reiterated (AKRO) at Strong Buy and Held Target at $64 on, Mar 20th, 2023


Published on 2024-10-28 02:20:55 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $64 on, Mar 20th, 2023.

Ed has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $65 on, Friday, January 27th, 2023